StocksMediumUpdated×3•Originally published 27 October 2026•Updated 28 October 2026•
1 min read
Beta Bionics Shares Eye Revenue Growth and 2027 Product Launch
Key Facts
1Beta Bionics reported its third-quarter financial results for 2026 on Tuesday.
Beta Bionics expects full-year 2026 revenue to range between $124 million and $126 million. The company also announced plans to launch its Mint product in the first quarter of 2027, following a third-quarter 2026 loss of $0.52 per share which was narrower than the $0.53 loss estimated by analysts.
BBNX closed at $20.51 on October 26, 2026, with the session seeing a high of $21.19 and a low of $19.08. Benzinga reported that the company discussed these financial projections and operational milestones during an earnings call with investors.